Download PDF
Semin Reprod Med 2015; 33(01): 030-034
DOI: 10.1055/s-0034-1395276
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Communicable Diseases

Erica J. Hardy
1   Department of Medicine, Women and Infants Hospital
,
Brenna L. Anderson
2   Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, Rhode Island
› Author Affiliations
Further Information

Publication History

Publication Date:
07 January 2015 (online)

    Permissions and Reprints

Abstract

Globally, infectious diseases often disproportionately affect women, and have implications for the health of future generations. The human immunodeficiency virus (HIV), tuberculosis, malaria, and schistosomiasis are four such pathogens. Infection with these organisms has a broad impact on maternal child health in many areas of the developing world, and global initiatives to control these diseases will significantly improve the health of generations to come.

Keywords

malaria - tuberculosis - HIV - schistosomiasis - women's health - global health - pregnancy
 

  • References

  • 1 UNAIDS. UNAIDS Report on the Global AIDS Epidemic. UNAIDS; 2013
    Google Scholar
  • 2 HIV in Women: Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/hiv/pdf/risk_women.pdf . Accessed on November 14, 2014
    PubMedGoogle Scholar
  • 3 Dunkle KL, Jewkes RK, Brown HC, Gray GE, McIntryre JA, Harlow SD. Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa. Lancet 2004; 363 (9419) 1415-1421
    CrossrefPubMedGoogle Scholar
  • 4 Maman S, Mbwambo JK, Hogan NM , et al. HIV-positive women report more lifetime partner violence: findings from a voluntary counseling and testing clinic in Dar es Salaam, Tanzania. Am J Public Health 2002; 92 (8) 1331-1337
    CrossrefPubMedGoogle Scholar
  • 5 Fonck K, Leye E, Kidula N, Ndinya-Achola J, Temmerman M. Increased risk of HIV in women experiencing physical partner violence in Nairobi, Kenya. AIDS Behav 2005; 9 (3) 335-339
    CrossrefPubMedGoogle Scholar
  • 6 Jewkes R, Nduna M, Levin J , et al. A cluster randomized-controlled trial to determine the effectiveness of Stepping Stones in preventing HIV infections and promoting safer sexual behaviour amongst youth in the rural Eastern Cape, South Africa: trial design, methods and baseline findings. Trop Med Int Health 2006; 11 (1) 3-16
    CrossrefPubMedGoogle Scholar
  • 7 Cohen MS, Chen YQ, McCauley M , et al; HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365 (6) 493-505
    CrossrefPubMedGoogle Scholar
  • 8 Grant RM, Lama JR, Anderson PL , et al; iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363 (27) 2587-2599
    CrossrefPubMedGoogle Scholar
  • 9 Choopanya K, Martin M, Suntharasamai P , et al; Bangkok Tenofovir Study Group. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2013; 381 (9883) 2083-2090
    CrossrefPubMedGoogle Scholar
  • 10 WHO. The Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. WHO; 2013
    Google Scholar
  • 11 Zaba B, Calvert C, Marston M , et al. Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa: secondary analyses of pooled community-based data from the network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA). Lancet 2013; 381 (9879) 1763-1771
    CrossrefPubMedGoogle Scholar
  • 12 Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. 2012. Available at: http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL . Accessed on November 14, 2014
    PubMedGoogle Scholar
  • 13 Centers for Disease Control and Prevention. Facts about malaria. Available at: http://www.cdc.gov/malaria/about/facts.html . Accessed on November 14, 2014
    PubMedGoogle Scholar
  • 14 World Health Organization, World Malaria Report—2011. Available at: http://www.who.int/malaria/world_malaria_report_2011/burdenestimatesbriefing2011.pdf . Accessed on November 14, 2014
    PubMedGoogle Scholar
  • 15 Ofori M, Ansah E, Agyepong I, Ofori-Adjei D, Hviid L, Akanmori B. Pregnancy-associated malaria in a rural community of Ghana. Ghana Med J 2009; 43 (1) 13-18
    PubMedGoogle Scholar
  • 16 Schantz-Dunn J, Nour NM. Malaria and pregnancy: a global health perspective. Rev Obstet Gynecol 2009; 2 (3) 186-192
    PubMedGoogle Scholar
  • 17 Garner P, Gülmezoglu AM. Drugs for preventing malaria in pregnant women. Cochrane Database Syst Rev 2006; (4) CD000169
    PubMedGoogle Scholar
  • 18 Kiwuwa MS, Mufubenga P. Use of antenatal care, maternity services, intermittent presumptive treatment and insecticide treated bed nets by pregnant women in Luwero district, Uganda. Malar J 2008; 7: 44
    CrossrefPubMedGoogle Scholar
  • 19 Orton LC, Omari AAA. Drugs for treating uncomplicated malaria in pregnant women. Cochrane Database Syst Rev 2008; (4) CD004912
    PubMedGoogle Scholar
  • 20 Status Report on Artemisinin Resistance, January 2014. Available at: http://www.who.int/malaria/publications/atoz/status_rep_artemisinin_resistance_jan2014.pdf . Accessed on November 14, 2014
    PubMedGoogle Scholar
  • 21 CDC | TB | Data and Statistics. Available at: http://www.cdc.gov/tb/statistics/default.htm . Accessed on November 14, 2014
    PubMedGoogle Scholar
  • 22 World Health Organization. Tuberculosis in Women. (2014). Available at: www.who.int/tb/challenges/hiv/tb_women_factsheet.pdf . Accessed on November 19, 2014
    PubMedGoogle Scholar
  • 23 Hamadeh MA, Glassroth J. Tuberculosis and pregnancy. Chest 1992; 101 (4) 1114-1120
    CrossrefPubMedGoogle Scholar
  • 24 Good Jr JT, Iseman MD, Davidson PT, Lakshminarayan S, Sahn SA. Tuberculosis in association with pregnancy. Am J Obstet Gynecol 1981; 140 (5) 492-498
    PubMedGoogle Scholar
  • 25 Carter EJ, Mates S. Tuberculosis during pregnancy. The Rhode Island experience, 1987 to 1991. Chest 1994; 106 (5) 1466-1470
    CrossrefPubMedGoogle Scholar
  • 26 Zenner D, Kruijshaar ME, Andrews N, Abubakar I. Risk of tuberculosis in pregnancy: a national, primary care-based cohort and self-controlled case series study. Am J Respir Crit Care Med 2012; 185 (7) 779-784
    CrossrefPubMedGoogle Scholar
  • 27 Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000; 49 (No. RR-6).
    PubMedGoogle Scholar
  • 28 Latent tuberculosis: a guide for primary health care providers. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for HIV/AIDS, viral hepatitis, STD and TB prevention, Division of Tuberculosis Prevention, Atlanta, Georgia. 2013. Available at: www.cdc.gov/tb/publications/ltbi/pdf/TargetedLTBI.pdf . Accessed on November 14, 2014
    PubMedGoogle Scholar
  • 29 Schaefer G. Female genital tuberculosis. Clin Obstet Gynecol 1976; 19 (1) 223-239
    CrossrefPubMedGoogle Scholar
  • 30 Muir DG, Belsey MA. Pelvic inflammatory disease and its consequences in the developing world. Am J Obstet Gynecol 1980; 138 (7, Pt 2): 913-928
    PubMedGoogle Scholar
  • 31 Ghosh K, Ghosh K, Chowdhury JR. Tuberculosis and female reproductive health. J Postgrad Med 2011; 57 (4) 307-313
    CrossrefPubMedGoogle Scholar
  • 32 Bothamley G. Drug treatment for tuberculosis during pregnancy: safety considerations. Drug Saf 2001; 24 (7) 553-565
    CrossrefPubMedGoogle Scholar
  • 33 Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Available at: http://whqlibdoc.who.int/publications/2011/9789241500708_eng.pdf . Accessed on November 14, 2014
    PubMedGoogle Scholar
  • 34 Hotez P, Whitham M. Helminth infections: a new global women's health agenda. Obstet Gynecol 2014; 123 (1) 155-160
    CrossrefPubMedGoogle Scholar
  • 35 WHO Schistosomiasis. Available at: http://www.who.int/mediacentre/factsheets/fs115/en/ . Accessed on November 14, 2014
    PubMedGoogle Scholar
  • 36 Friedman JF, Mital P, Kanzaria HK, Olds GR, Kurtis JD. Schistosomiasis and pregnancy. Trends Parasitol 2007; 23 (4) 159-164
    CrossrefPubMedGoogle Scholar
  • 37 Coutinho HM, McGarvey ST, Acosta LP , et al. Nutritional status and serum cytokine profiles in children, adolescents, and young adults with Schistosoma japonicum-associated hepatic fibrosis, in Leyte, Philippines. J Infect Dis 2005; 192 (3) 528-536
    CrossrefPubMedGoogle Scholar
  • 38 Friedman JF, Kanzaria HK, Acosta LP , et al. Relationship between Schistosoma japonicum and nutritional status among children and young adults in Leyte, the Philippines. Am J Trop Med Hyg 2005; 72 (5) 527-533
    PubMedGoogle Scholar
  • 39 Friedman JF, Kanzaria HK, McGarvey ST. Human schistosomiasis and anemia: the relationship and potential mechanisms. Trends Parasitol 2005; 21 (8) 386-392
    CrossrefPubMedGoogle Scholar
  • 40 Moormann AM, Sullivan AD, Rochford RA , et al. Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation. J Infect Dis 1999; 180 (6) 1987-1993
    CrossrefPubMedGoogle Scholar
  • 41 Kurtis JD, Higashi A, Wu HW , et al. Maternal Schistosomiasis japonica is associated with maternal, placental, and fetal inflammation. Infect Immun 2011; 79 (3) 1254-1261
    CrossrefPubMedGoogle Scholar
  • 42 McDonald EA, Pond-Tor S, Jarilla B , et al. Schistosomiasis japonica during pregnancy is associated with elevated endotoxin levels in maternal and placental compartments. J Infect Dis 2014; 209 (3) 468-472
    CrossrefPubMedGoogle Scholar
  • 43 Allen HE, Crompton DWT, de Silva N, LoVerde PT, Olds GR. New policies for using anthelmintics in high risk groups. Trends Parasitol 2002; 18 (9) 381-382
    CrossrefPubMedGoogle Scholar